Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ITGR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 1.356B
March 31, 2026 1.373B
December 31, 2025 1.303B
September 30, 2025 1.302B
June 30, 2025 1.312B
March 31, 2025 1.346B
December 31, 2024 1.096B
September 30, 2024 1.162B
June 30, 2024 1.204B
March 31, 2024 1.226B
December 31, 2023 1.044B
September 30, 2023 1.006B
June 30, 2023 1.053B
March 31, 2023 1.072B
December 31, 2022 998.41M
September 30, 2022 1.001B
June 30, 2022 1.012B
March 31, 2022 893.89M
December 31, 2021 887.89M
September 30, 2021 672.04M
June 30, 2021 711.82M
March 31, 2021 732.28M
December 31, 2020 769.12M
September 30, 2020 878.14M
June 30, 2020 1.008B
Date Value
March 31, 2020 873.81M
December 31, 2019 851.89M
September 30, 2019 866.64M
June 30, 2019 902.73M
March 31, 2019 945.42M
December 31, 2018 925.51M
September 30, 2018 954.19M
June 30, 2018 1.539B
March 31, 2018 1.562B
December 31, 2017 1.609B
September 30, 2017 1.630B
June 30, 2017 1.665B
March 31, 2017 1.702B
December 31, 2016 1.730B
September 30, 2016 1.746B
June 30, 2016 1.757B
March 31, 2016 1.763B
December 31, 2015 1.714B
September 30, 2015 180.00M
June 30, 2015 182.50M
March 31, 2015 185.00M
December 31, 2014 187.50M
September 30, 2014 190.00M
June 30, 2014 192.50M
March 31, 2014 195.00M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 97.53M
Integra LifeSciences Holdings Corp. 2.035B
Abbott Laboratories 32.61B
AngioDynamics, Inc. 9.66M
Alphatec Holdings, Inc. 597.42M